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Summary
Nicotine, the primary addictive substance in tobacco, induces profound behavioral responses in
mammals, but the underlying genetic mechanisms are not well understood. Here we develop a C.
elegans model of nicotine-dependent behavior. We show that worms exhibit behavioral responses
to nicotine that parallel those observed in mammals, including acute response, tolerance,
withdrawal and sensitization. These nicotine responses require nicotinic acetylcholine receptor
(nAChR) family genes that are known to mediate nicotine dependence in mammals, suggesting
functional conservation of nAChRs in nicotine responses. Importantly, we find that mutant worms
lacking TRPC (transient-receptor-potential canonical) channels are defective in response to
nicotine and that such a defect can be rescued by a human TRPC channel, revealing an unexpected
role for TRPC channels in regulating nicotine-dependent behavior. Thus, C. elegans can be used
to characterize known genes as well as to identify new genes regulating nicotine responses.
Introduction
Nicotine dependence is a worldwide health problem and represents the leading preventable
cause of death in industrialized countries (Champtiaux and Changeux, 2004; Laviolette and
van der Kooy, 2004). The primary molecular target of nicotine is nicotinic acetylcholine
receptors (nAChRs), a family of pentameric calcium-permeable cation channels
(Champtiaux and Changeux, 2004). In mammals, nicotine binds to nAChRs in the ventral
tegmental area, leading to stimulation of the mesolimbic dopamine system (Laviolette and
van der Kooy, 2004). While much is known about the role of nicotine in directly modulating
the function of nAChRs, the genetic mechanisms by which such modulation leads to
prolonged behavioral and neurological changes are poorly understood.
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Due to their simple nervous system and amenability to genetic manipulation, invertebrate
organisms such as C. elegans and Drosophila have been widely utilized as genetic models to
study various phenomena in neurobiology, including substance dependence. For example,
recent studies in Drosophila have provided new insights into the mechanisms of alcohol
tolerance/intoxication and cocaine sensitivity, and work in C. elegans has identified novel
players involved in alcohol intoxication (Andretic et al., 1999; Bainton et al., 2005; Davies
et al., 2003; Scholz et al., 2005). The C. elegans genome encodes 28 nAChR genes, many of
which have been shown to form functional nAChRs in heterologous systems (Jones and
Sattelle, 2004). While the role of nicotine in regulating the activity of muscle cells (e.g. egg-
laying and body-wall muscles) has been well characterized (Gottschalk et al., 2005; Lewis et
al., 1980; Waggoner et al., 2000), the effects of nicotine on the function of the nervous
system, which mediates nicotine dependence in vertebrates, have not been evaluated.
TRP (transient-receptor-potential) channels represent a superfamily of cation channels
conserved from worms to humans and comprise seven subfamilies (TRPC, TRPV, TRPM,
TRPN, TRPA, TRPP and TRPML) (Montell, 2005; Ramsey et al., 2006). The founding
members of the TRP superfamily are the TRPC (TRP-Canonical) channels, which can be
activated following the stimulation of phospholipase C and/or depletion of internal calcium
stores (Montell, 2005). However, the precise mechanisms leading to TRPC activation
remain unclear and somewhat controversial. Studies in cell culture systems have implicated
TRPCs in a wide variety of physiological processes in mammals ranging from muscle
relaxation/contraction, fluid secretion, growth cone guidance and morphology, to acrosome
reaction (Montell, 2005; Ramsey et al., 2006). Nevertheless, the genetic evidence supporting
such functions is rather limited.
In the current study, we developed a C. elegans model of nicotine-dependent behavior. We
show that worms display acute and chronic behavioral responses to nicotine that parallel
those observed in mammals. These responses require nAChRs that are known to be critical
for nicotine dependence in mammals. We have also identified TRPC channels as novel
proteins important for nicotine-dependent behavior. TRPC channels functionally regulate
nicotine-induced cellular responses in the locomotion circuitry. Our results suggest that C.
elegans can be used as a genetic model for identifying and characterizing neuronal genes
regulating nicotine responses.
Results
Worms respond to acute nicotine exposure, develop tolerance to chronic nicotine
treatment, and exhibit withdrawal responses upon nicotine cessation
In rodent models, nicotine stimulates locomotor activity in naïve animals, though it initially
induces transient hypoactivity (Dwoskin et al., 1999). Chronic nicotine treatment adapts
animals to nicotine (Dwoskin et al., 1999; Laviolette and van der Kooy, 2004). In addition,
nicotine cessation evokes withdrawal symptoms (Kenny and Markou, 2001). To quantify the
effects of nicotine on worm locomotion, we used a worm tracking system that records worm
locomotion and reports its activity, such as locomotion velocity, in real time (Li et al.,
2006).
We first examined the locomotion behavior of naïve animals. After being transferred to a
new environment (i.e. a fresh plate with bacteria), the animals exhibited a continuous decay
in locomotion speed until reaching a relatively steady state (Figure 1A and S2D), consistent
with previous observations (Zhao et al., 2003). However, when assayed on plates containing
nicotine, the animals displayed a distinct locomotion behavior: After a brief rapid decay in
locomotion speed, the animals then began to gradually speed up their locomotion (Figure
1B). We named this phenomenon “locomotion-stimulation”. The locomotion-stimulation
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phase, which was not seen in naïve animals, became evident starting at ~4 minutes after the
acute nicotine incubation and perdured until the speed plateaued (Figure 1B). Such a
response to nicotine was dose-dependent and peaked at around 1.5 μM (Figure 1E).
Interestingly, the nicotine concentration in human blood peaks at ~500 nM after
consumption of one cigarette (Pidoplichko et al., 1997).
We next tested the long-term effects of nicotine on locomotion and found that after chronic
nicotine treatment, worms developed tolerance to nicotine in a time-dependent manner
(Figure 1C, 1F and S2E). As a result, these nicotine-adapted animals behaved similarly to
naïve animals on nicotine-free plates, demonstrating that chronic nicotine treatment elicits
tolerance (adaptation) in C. elegans (Figure 1C and 1F).
To test the effects of nicotine withdrawal, we moved the animals that were chronically
treated (>16 hrs) with nicotine to nicotine-free plates. In response to such nicotine cessation,
these nicotine-adapted animals began to increase their locomotion speed at ~4 minutes after
nicotine withdrawal and displayed a locomotion-stimulation phase similar to that observed
in naïve animals responding to acute nicotine exposure (Figure 1D). This suggests that these
nicotine-adapted animals became dependent on nicotine for their naïve-like behavior on
nicotine plates (Figure 1D). These results indicate that nicotine cessation can induce
withdrawal responses in C. elegans.
Worms can be behaviorally sensitized to nicotine by repeated intermittent nicotine
challenges
In vertebrates, repeated intermittent administrations of nicotine can sensitize an animal’s
response to nicotine, a process believed to be critical for the development of nicotine
dependence (Dwoskin et al., 1999; Laviolette and van der Kooy, 2004). To test whether
worms can be sensitized to nicotine, we treated naïve animals for 20 minutes with a lower
concentration of nicotine that did not induce significant locomotion-stimulation in naïve
animals (Figure 2A). Subsequently, we moved these nicotine-treated animals to nicotine-
free plates for a recovery period before subjecting them to another round of treatment. After
three doses of such treatment, the same low concentration of nicotine then evoked robust
locomotion-stimulation in these animals, indicating that worms can be sensitized to nicotine
(Figure 2B and 2C).
It may be argued that the observed nicotine sensitization might be caused by the
accumulation of nicotine in worms. Two observations argue against this possibility. First,
nicotine sensitization can only be seen with intermittent nicotine treatments (Figure 2D),
whereas continuous nicotine treatments, which would presumably result in the accumulation
of more nicotine, failed to induce sensitization (Figure 2D). Second, the sensitization effect
did not peak until the treated animals rested on nicotine-free plates for one hour after the last
dose of nicotine treatment (Figure 2E), providing further evidence that the observed
sensitization effect was not simply due to the accumulation of nicotine.
Taken together, our data show that worms exhibit nicotine-dependent behavior: they
respond to acute nicotine treatment, develop tolerance to chronic nicotine exposure, display
withdrawal symptoms upon nicotine cessation, and become sensitized to nicotine after
repetitive nicotine challenges. These behavioral responses to nicotine seem to parallel those
observed in vertebrates.
Nicotine-dependent behavior requires nAChRs
Having developed a model for characterizing nicotine-dependent behavior, we then asked
what genes may underlie this behavior in C. elegans. In vertebrates, the psychostimulatory
effects of nicotine require nicotinic acetylcholine receptors (nAChRs), the molecular target
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of nicotine (Champtiaux and Changeux, 2004). As a first step to test whether these receptors
are also required for nicotine responses in C. elegans, we challenged worms with DHβE, a
nAChR competitive antagonist (Champtiaux and Changeux, 2004). This antagonist
suppressed the acute nicotine response as well as nicotine sensitization in wild-type animals
(Figure 3A). In vertebrates, nAChR antagonists can mimic the effects of nicotine cessation
by inducing withdrawal-like symptoms in nicotine-treated animals in the presence of
nicotine (Kenny and Markou, 2001). We also observed a similar phenomenon in C. elegans
induced by DHβE (Figure 3B). These results provide strong pharmacological evidence that
nicotine-dependent behavior in C. elegans requires nAChRs.
We next sought to provide genetic evidence for the requirement of nAChRs for nicotine
responses in C. elegans. The C. elegans genome encodes 28 nAChRs (Jones and Sattelle,
2004), most of which have mutants available (Figure 3C). We screened these mutants and
found that acr-15 and acr-16 mutant worms lacked response to acute nicotine treatment
(Figure 3D), though both mutants were otherwise superficially wild-type [(Francis et al.,
2005; Touroutine et al., 2005) and Figure S1]. As a result of this defect, the mutant worms
were also defective in nicotine withdrawal and sensitization (Figure S2A–B). Thus, ACR-15
and ACR-16 are required for nicotine-dependent behavior. unc-63 and unc-38 mutants were
also defective in response to nicotine (Figure 3D); however, it remains possible that such a
deficit might result from a nonspecific defect in locomotion because both mutants
particularly unc-63 are severely uncoordinated (Culetto et al., 2004; Fleming et al., 1997).
Nonetheless, our results demonstrate that nicotine-dependent behavior in C. elegans requires
nAChRs.
The mouse nAChR α4β2 can functionally substitute for worm nAChRs in nicotine-
dependent behavior
The essential roles of nAChRs in nicotine-dependent behavior prompted us to explore the
possibility that mammalian nAChRs may functionally substitute for C. elegans nAChRs in
this behavior. As the mouse α4β2 heteromeric channel is the only nAChR that has thus far
been found to be essential and sufficient for mediating nicotine dependence in mice
(Champtiaux and Changeux, 2004; Maskos et al., 2005; Tapper et al., 2004), we expressed
this mouse nAChR as a transgene in the acr-16 mutant background under the acr-16
promoter. We found that mouse α4β2 rescued the mutant phenotype in acute response,
withdrawal and sensitization, though the transgene did not significantly affect locomotion of
wild-type worms (Figure 3E, S2A–B and data not shown). Another mouse nAChR, α7,
failed to rescue the mutant phenotype (Figure 3E). While it is possible that such a negative
result might simply stem from aberrant expression of mouse α7 in worm cells, it is
nonetheless noteworthy that knockout studies in mice do not support an essential role for α7
in nicotine dependence (Orr-Urtreger et al., 1997). The observation that mammalian
nAChRs can functionally substitute for their C. elegans homologue in response to nicotine
strongly suggests that at least some of the genes regulating nicotine responses in mammals
are functionally conserved in C. elegans.
nAChRs primarily act in neurons to mediate nicotine-dependent behavior
Both neuron- and muscle-type nAChRs are present in mammals; however, it is the neuronal,
but not the muscular nAChRs, that primarily mediate the psychostimulatory effects of
nicotine (Champtiaux and Changeux, 2004). We therefore wondered whether this is also the
case with C. elegans nAChRs. However, acr-16 is not neuron-specific, has strong
expression in muscle cells, and has been reported to function as a nAChR in the
neuromusclular junction [(Ballivet et al., 1996; Francis et al., 2005; Touroutine et al., 2005)
and Figure S3B]. Similarly, acr-15 is also expressed in both neurons and muscles (Figure
S3A). In the nervous system, acr-15 can be found in interneurons (including command
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interneurons), motor neurons and pharyngeal neurons (Figure S3A). We generated
transgenic animals expressing ACR-15 specifically in neurons or muscles in the acr-15
mutant background under a neuron- or muscle-specific promoter, respectively. The neuronal
but not the muscular expression of ACR-15 rescued the nicotine defects in acr-15 mutant
animals including acute response, withdrawal and sensitization (Figure 4A and Figure S2A–
B). Similar results were also obtained with acr-16 (Figure 4A and Figure S2A–B). It should
be noted that nicotine can affect muscle function under certain conditions. For example, high
concentrations of nicotine paralyze worms by acting in the muscle (Gottschalk et al., 2005).
Nevertheless, under our conditions, nAChRs seem to primarily act in neurons to mediate
their function in nicotine responses.
Command interneurons are important for mediating nicotine responses
Interestingly, expression of acr-15 under the glr-1 promoter rescued the nicotine phenotype
in acr-15 mutants (Figure 4A). This promoter drives expression primarily in command
interneurons, the central players in the locomotion circuitry, and a few other neurons (Hart
et al., 1995; Maricq et al., 1995), suggesting that acr-15 may act in some of these neurons to
mediate its function in nicotine-dependent behavior. The same promoter, however, did not
significantly rescue the acr-16 mutant phenotype (Figure 4A), indicating the involvement of
additional or different sets of neurons for acr-16 function in nicotine-dependent behavior.
Thus, we chose to focus on acr-15 for further characterization.
The observation that the glr-1 promoter-driven acr-15 rescued the mutant phenotype
suggests that command interneurons, the central players in the locomotion circuitry, may be
important for mediating nicotine-dependent behavior. Therefore, we killed these neurons
(AVA, AVB, AVD and PVC) with a laser. Worms lacking PVC or AVD did not exhibit a
significant defect in response to nicotine incubation (Figure 4B). In contrast, ablation of
AVA rendered worms unresponsive to nicotine, demonstrating an essential role for this
neuron in nicotine-dependent behavior (Figure 4B). Ablation of AVB also impaired worms’
response to nicotine, though the ablated worms retained residual nicotine response (Figure
4B). However, unlike other command interneurons, AVB ablation makes worms severely
uncoordinated [(Chalfie et al., 1985) and data not shown]; thus, it remains possible that the
observed nicotine defects in these worms may result from a nonspecific deficit in
locomotion. As such, we decided to focus on AVA for further characterization.
To provide physiological evidence that command interneurons are important for nicotine
responses, we recorded the activity of these neurons by calcium imaging of live animals
expressing G-CaMP, a genetically-encoded calcium sensor (Nakai et al., 2001). G-CaMP
and cameleon have been successfully used in C. elegans to monitor neuronal activity (Kahn-
Kirby et al., 2004; Li et al., 2006; Suzuki et al., 2003). DsRed was co-injected as a reference
marker, allowing for ratiometric imaging. We focused on AVA because of its essential role
in nicotine-dependent behavior and its expression of ACR-15 (Figure 4A and Figure S3A).
In naïve animals, acute nicotine perfusion elicited robust calcium responses in AVA (Figure
4C and 4G). In contrast, such responses were greatly reduced in the animals that were
behaviorally adapted to nicotine by chronic nicotine treatment (Figure 4D and 4G), though
ACR-15 was up-regulated in these animals (Figure S3C–D). Chronic nicotine treatment also
up-regulates nAChRs in mammals, the mechanism of which is not fully understood (Marks
et al., 1986). Notably, in the animals that were behaviorally sensitized to nicotine, the
nicotine-induced calcium responses were significantly potentiated (Figure 4E and 4G).
Importantly, very little response to nicotine perfusion was observed in acr-15 mutant
animals (Figure 4F and 4G), suggesting that ACR-15 is important for mediating the
observed calcium responses. In support of this in vivo observation, we found that when
expressed in HEK293T cells, ACR-15 was capable of forming a functional nAChR that can
be activated by nicotine (Figure S4). Taken together, these results provide a cellular and
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molecular mechanism for nicotine regulation of locomotion behavior, and reveal a
correlation between behavioral responses and cellular physiology.
TRPC channels are required for nicotine-dependent behavior
Having examined some genes known to regulate nicotine responses, we then sought to
identify novel genes involved in the process. In an effort to characterize C. elegans TRPC
channels, we became intrigued by the possibility that these channels might regulate nicotine-
dependent behavior. As a first step, we challenged wild-type animals with 2-APB, a TRPC
channel inhibitor (Montell, 2005; Ramsey et al., 2006), and found that this drug abolished
the response to acute nicotine treatment as well as to nicotine withdrawal in wild-type
animals, suggesting that TRPC channels are required for nicotine-dependent behavior
(Figure 5A and Figure S5A). However, 2-APB impinges on several other targets in addition
to TRPC channels (Montell, 2005; Ramsey et al., 2006). Therefore, we decided to examine
TRPC mutants.
The C. elegans genome encodes three TRPC channel homologues, TRP-1, TRP-2 and
TRP-3 (Xu and Sternberg, 2003). They all share the same domain structure with human and
fly TRPCs (Figure 5B). These include 3–4 ankyrin repeats and a coil-coil domain in the N-
terminus followed by six putative transmembrane domains and a TRP domain in the C-
terminal cytoplasmic tail (Figure 5B). We isolated one trp-1 allele that deleted the promoter
region as well as the majority of the N-terminus, and one trp-2 allele that ablated half of the
transmembrane domains (Figure 5C and 5D). Both alleles are likely to be null.
Both trp-1 and trp-2 mutant animals were superficially wild-type (Figure S1 and data not
shown), though some moderate locomotion abnormalities can be detected with our tracking
system (Feng and Xu, unpublished observations). Importantly, both trp mutants lacked
response to acute nicotine treatment, consistent with our pharmacological results (Figure
5E). As a result of this defect, these mutants were also defective in nicotine withdrawal and
sensitization (Figure S5A–B). As a control, mutants lacking the sperm-specific TRPC
channel TRP-3, the TRPV channel OSM-9 or the TRPM channel GTL-1 all responded
normally to nicotine incubation (Colbert et al., 1997; Teramoto et al., 2005; Xu and
Sternberg, 2003) (Figure 5E). Transgenic expression of wild-type copies of the trp-2 gene in
the trp-2 mutant background restored mutant animals’ responses to nicotine including acute
response, withdrawal and sensitization (Figure 5E and Figure S5A–B). Similar results were
obtained with trp-1 rescue (Figure 5E and Figure S5A–B). Therefore, TRPC channels are
required for nicotine-dependent behavior in C. elegans.
TRP-1 has been reported to be expressed in multiple classes of neurons, such as interneurons
(including command interneurons), motor neurons, pharyngeal neurons and sensory neurons
(Colbert et al., 1997). TRP-2 is also expressed in these types of neurons (Figure S5D–E).
Expression of TRP-2 under the glr-1 promoter can rescue the trp-2 mutant phenotype,
including acute response, withdrawal and sensitization (Figure 5E and Figure S5A–B).
Similar results were obtained for trp-1 (Figure 5E). This promoter was also able to rescue
the acr-15 mutant phenotype (Figure 4A), suggesting that TRPC channels and ACR-15
might act in the same groups of neurons or circuits to regulate nicotine-dependent behavior.
TRP-2 promotes receptor-operated calcium entry in vitro
We then asked whether worm TRPCs can function, like their mammalian counterparts, as
receptor-operated channels (Montell, 2005; Ramsey et al., 2006). Although the precise
mechanisms leading to activation of mammalian TRPCs remain uncertain, they all can be
activated following the stimulation of phospolipase Cβ (PLCβ) when expressed in
heterologous systems (Montell, 2005; Ramsey et al., 2006). We used TRP-2 as an example
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and isolated its cDNA by RT-PCR. Expression of TRP-2 in HEK293T cells promoted
receptor-operated calcium entry elicited by perfusion of carbachol (Figure 6A, 6B and 6G).
Carbachol is known to induce such calcium entry by stimulating PLCβ via its endogenous
receptors in HEK293 cells that are coupled to heterotrimeric G-proteins (Montell, 2005;
Ramsey et al., 2006). Further evidence came from the observation that the TRP-2-dependent
activity in HEK293T cells can be blocked by U73122, a PLC inhibitor (Figure 6H)
(Montell, 2005; Ramsey et al., 2006). As is the case with mammalian TRPCs, the TRP-2-
dependent activity in HEK293T cells was sensitive to 2-APB (Figure 6H). In addition,
TRP-2 appeared to be permeable to Ba2+ and Sr2+, a feature shared by several mammalian
TRPCs (Figure 6C–6G) (Montell, 2005; Ramsey et al., 2006). These observations provide
strong evidence that TRP-2 can function as a receptor-operated channel either by its own or
by interacting with endogenous TRP proteins.
PLCβ/EGL-8 is required for nicotine-dependent behavior
The requirement of PLCβ for TRP-2 activation in vitro raises the possibility that PLCβ may
play a role in nicotine-dependent behavior in vivo. egl-8 encodes the worm PLCβ homolog
that is ubiquitously expressed in the nervous system (Lackner et al., 1999; Miller et al.,
1999). egl-8 mutant animals did not exhibit significant response to acute nicotine incubation
or withdrawal (Figure 7A and Figure S6A). We also examined the role of Gq/11, because
these proteins are known to function upstream of PLCβ (Montell, 2005). A reduction-of-
function Gq/egl-30 mutant lacked response to nicotine incubation; however, we cannot
exclude the possibility that such a defect might result from a nonspecific deficit in
locomotion, because this mutant is severely uncoordinated (Brundage et al., 1996; Miller et
al., 1999). Nonetheless, our results demonstrate an in vivo role for PLCβ in regulating
nicotine-dependent behavior in C. elegans, and are also consistent with the role of TRPC
channels in this behavior.
Human TRPC3 can functionally substitute for C. elegans TRP-2 in nicotine-dependent
behavior
In light of the functional similarity between TRP-2 and mammalian TRPCs in heterologous
systems, we reasoned that mammalian TRPCs might be able to substitute for the function of
TRP-2 in nicotine-dependent behavior in C. elegans. To explore this possibility, we
generated transgenic animals expressing human TRPC genes in the trp-2 mutant background
under the trp-2 promoter. Three human TRPC genes (hTRPC1, 3 and 4) were tested, with
each representing a subgroup of the human TRPC subfamily (Montell, 2005; Ramsey et al.,
2006). While negative results were obtained with hTRPC1 and 4, expression of hTRPC3
restored the responses of trp-2 mutant animals to nicotine including acute response,
withdrawal and sensitization (Figure 7A and Figure S6). These results reveal functional
conservation of TRPC channels in regulating nicotine-dependent behavior.
TRPC channels are important for nicotine-induced calcium responses in command
interneurons
The question arises as to how TRPC channels regulate nicotine-dependent behavior. One
possibility would be that nAChRs may depend on TRPC channels for their expression.
However, this does not seem to be case. For example, TRP-2 was not required for ACR-15
expression (Figure S3E and data not shown). As TRPCs and ACR-15 may act in the same
groups of neurons or circuits, we tested whether TRPC channels can functionally regulate
nAChR activity by imaging nicotine-induced calcium responses in live animals expressing
the genetically-encoded calcium sensor G-CaMP. We found that nicotine-induced calcium
responses in the command interneuron AVA were greatly reduced in trp-2 and trp-1 mutant
worms (Figure 7B–E). Thus, it appears that TRPC channels can functionally regulate
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nicotine-induced neuronal activity in the locomotion circuitry, providing a cellular
mechanism for TRPC channel regulation of nicotine-dependent behavior.
Discussion
C. elegans can be used as a genetic model to characterize genes regulating nicotine
responses
In the current study, we developed a C. elegans model of nicotine-dependent behavior. Our
results indicate that C. elegans displays several types of behavioral responses to nicotine that
parallel those observed in vertebrates. These include acute response, tolerance, withdrawal
and sensitization. In addition, we show that nicotine responses in C. elegans require
nAChRs, the molecular targets of nicotine that are known to mediate nicotine dependence in
mammals (Champtiaux and Changeux, 2004; Laviolette and van der Kooy, 2004). These
results demonstrate that at least some of the genes regulating nicotine responses in mammals
are functionally conserved in C. elegans, and suggest that C. elegans is a valuable system
for characterizing genes regulating nicotine responses.
While only 17 nAChR genes are present in mammals, the C. elegans genome encodes 28
such genes. Among the worm nAChR genes that have been examined for expression
patterns, all have been found to be expressed in neurons (Jones and Sattelle, 2004).
Although much is known about the role of these nAChRs in regulating muscle activity
(Francis et al., 2005; Gottschalk et al., 2005; Richmond and Jorgensen, 1999; Touroutine et
al., 2005; Waggoner et al., 2000), their functions in the nervous system are not well
understood. We have shown that at least two nAChR genes, acr-15 and acr-16, are required
for nicotine-dependent behavior. Both nAChRs can be activated by nicotine when expressed
in heterologous systems [Figure S4 and (Ballivet et al., 1996)]. Although these two nAChRs
are expressed in both neurons and muscles, as is the case with their mammalian
counterparts, we have found that under our conditions they primarily act in neurons to
regulate nicotine-dependent behavior. One site of action for ACR-15 seems to be in the
command interneurons. Nevertheless, it remains unclear in which neurons ACR-16 acts to
mediate its function in nicotine responses. Nicotine dependence in mammals is a highly
complex phenomenon entailing the function and coordination of multiple nAChR genes and
brain regions. In worms, it may also involve the action of multiple nAChRs expressed in
different classes of neurons that are directly or indirectly connected to the locomotion
circuitry.
Our laser ablation and calcium imaging experiments suggest that command interneurons are
important for nicotine-dependent behavior. This is consistent with the critical role of these
neurons in locomotion (Chalfie, 1988). Nevertheless, our results do not exclude the
involvement of other types of neurons in regulating nicotine-dependent behavior. Among
the four major pairs of command interneurons, AVA neurons are essential for nicotine-
dependent behavior; AVB neurons may also play an important role. One function for AVA
neurons is to regulate spontaneous reversal frequency during locomotion (Chalfie et al.,
1985; Zheng et al., 1999). However, these neurons also receive synaptic input from as well
as synapse onto other command interneurons including AVB and PVC, both of which are
known to regulate forward movement (Chalfie et al., 1985; White et al., 1986). Upon
nicotine stimulation, AVA and AVB may tune the activity of the locomotion circuitry,
leading to the observed behavioral effects.
TRPC channels, a novel group of proteins regulating nicotine responses
We have also begun to identify novel proteins regulating nicotine-dependent behavior in C.
elegans and found that TRPC channels are required for this behavior. Specifically, trp
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mutant worms are defective in the acute nicotine response, which might lead to defects of
these mutants in other nicotine responses such as nicotine withdrawal and sensitization. The
role of TRPC channels in nicotine responses is also supported by the observation that PLCβ,
a protein important for TRPC channel activation, is critical for nicotine-dependent behavior
in C. elegans.
How do TRPC channels regulate nicotine-dependent behavior? Our rescuing experiments
suggest that TRPC channels and the nAChR ACR-15 may act in the same groups of neurons
or circuits to mediate their function in nicotine responses. Indeed, worms lacking TRPC
channels are defective in nicotine-induced, ACR-15-dependent calcium responses in some
command interneurons. Thus, while other mechanisms may also contribute, one mechanism
by which TRPC channels regulate nicotine-dependent behavior appears to be through
functionally modulating nicotine-induced command interneuron activity in the locomotion
circuitry. TRPC channels may do so by acting directly in command interneurons and/or
indirectly via network activity.
All six human TRPC channels are expressed in the central nervous system (CNS) (Montell,
2005; Ramsey et al., 2006). Despite extensive in vitro studies in cell culture systems
implicating mammalian TRPC channels in various neuronal activities in the CNS, such as
synaptic transmission, growth cone guidance and morphology, and neurite extension
[reviewed in (Ramsey et al., 2006)], the genetic evidence supporting such roles for these
channels is still lacking. Our studies identify a novel role for TRPCs in nervous system
function, and reveal an unexpected functional link between TRP family channels and
nicotinic signaling. The observation that a human TRPC gene can functionally substitute for
a C. elegans TRPC channel also raises the possibility that these channels might regulate
nicotine dependence and perhaps other types of substance dependence in mammals.
Experimental procedures
Genetics and molecular biology
The following mutant alleles were used in the study: acr-5(ok180), acr-8 (ok1240),
acr-9(ok933), acr-11(ok1345), acr-12(ok367), acr-14(ok1155), acr-15(ok1214),
acr-16(ok789), acr-18(ok1285), acr-19(ok967), acr-21(ok1314), deg-2(u695)deg-3(u662),
deg-3(tu1851), eat-2(ad465), eat-4(ky5), egl-8(n488), egl-30(md186), gtl-1(ok375),
lev-1(e211), lev-8(x15), osm-9(ky10), trp-1(sy690), trp-2(sy691), trp-3(sy693), unc-29(x29),
unc-38 (x20), and unc-63(x13).
To generate the unc-119 promoter-driven transgenic lines, the unc-119 promoter was first
amplified by PCR from a plasmid (PBY103), fused by PCR with a PCR fragment (amplified
from genomic DNA) encoding the coding region of acr-15 and acr-16, and injected into the
acr-15(ok1214) and acr-16(ok789) mutant background, respectively. Transgenic lines
expressing the myo-3 and glr-1 promoter-driven transgenes were generated with the same
strategy. The myo-3 promoter and glr-1 promoter was amplified by PCR from pPD136.64
(A. Fire) and genomic DNA, respectively (Hart et al., 1995; Maricq et al., 1995). To make
transgenic worms expressing the transgene Pacr-16::mouse α4β2, the acr-16 promoter (~6
kb) was amplified by PCR from genomic DNA, fused by PCR with a PCR fragment of the
mouse α4 cDNA orβ2 cDNA coding region linked to unc-54 3′ UTR, respectively, and co-
injected at a ratio of 2:3 into the acr-16(ok789) mutant background. To generate transgenic
lines expressing Ptrp-2::hTRPC3, the trp-2 promoter (~3.5 kb) was amplified from the
cosmid R06B10, fused by PCR with a PCR fragment of human TRPC3 cDNA coding region
linked to the unc-54 3′ UTR, and directly injected into the trp-2(sy691) mutant background.
The Ptrp-2::hTRPC1 and Ptrp-2::hTRPC4 transgenes were constructed with the same
strategy. The cosmids ZC21 and R06B10 were used to rescue the trp-1(sy690) and
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trp-2(sy691) mutants, respectively. At least two independent lines were analyzed for each
transgene. Both trp alleles were backcrossed to N2 for seven times before behavioural
analysis.
Cell culture and calcium imaging
Cell culture and calcium imaging were performed as previously described (Li et al., 2006;
Xu and Sternberg, 2003). See details in Supplemental Data.
Behavioral analysis
L4 hermaphrodites were picked 16 hours before behavioral analysis. The NGM plates used
for tracking were freshly spread with a thin layer of E. coli OP50 five minutes prior to
tracking. Tracking was performed at 20–21°C and at a relative humidity of ~40% with the
lid off. The tracking system consists of a stereomicroscope (Zeiss Stemi 2000C) mounted
with a digital camera (Cohu 7800), a digital motion system (Parker Automation) that follows
worm movement, and a home-developed software package. To record locomotion, animals’
images were grabbed at a rate of 2 Hz for 16 mins. The locomotion velocity of the animal at
each time point, computed as centroid displacement (mm) per second, was plotted and
displayed in real time during tracking. The vision/motion data were also compressed,
integrated and stored as a commonly used multimedia file format (AVI). Nicotine was
included in media right before plates were poured. DHβE and 2-APB were directly spread
on the surface of NGM plates and allowed to diffuse for >16 hours prior to use. Animals
were pre-incubated with DHβE for 1 hour prior to analyzing their response to nicotine.
Behavioral quantification
Methods for quantifying locomotion-stimulation are described in the Supplemental Data.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. C. elegans responds to acute nicotine treatment, develops tolerance to chronic nicotine
exposure, and exhibits withdrawal symptoms upon nicotine cessation
(A) The locomotion activity (centroid speed) of naïve animals (N2) versus time on nicotine-
free plates. Naïve wild-type animals picked to a fresh plate moved at high speed initially
because of the mechanical stimuli resulting from picking. Speed during the first 1.5 mins is
not shown due to high variations. See Figure S2D for longer time points. Shown is a sample
trace averaged from 10 animals.
(B) Acute nicotine response. Assays were performed as in (A) except on plates containing
1.5 μM nicotine
(C) Worms become adapted to nicotine after chronic nicotine treatment. Worms treated with
1.5 μM nicotine overnight were analyzed for their response to nicotine on nicotine plates.
(D) Nicotine cessation induces withdrawal responses. Worms treated with 1.5 μM nicotine
for 16 hours were moved to nicotine-free plates.
(E) Nicotine responses in naïve animals are dose-dependent. The locomotion-stimulation
index was used to quantify nicotine effects as described in supplemental material.
(F) The time course of nicotine tolerance (adaptation). Worms were treated with 1.5 μM
nicotine for various lengths of time, and their response to nicotine was subsequently
analyzed on plates containing the same concentration of nicotine. n≥10. Error bars represent
SD.
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Figure 2. Repeated intermittent nicotine treatments sensitize worms’ response to nicotine
(A) Lack of significant locomotion-stimulation in pre-sensitized animals. Wild-type naïve
animals were assayed on plates containing 500 nM nicotine. Shown is a sample trace
averaged from 10 animals.
(B) Behavioral sensitization by repeated intermittent nicotine treatments. Wild-type worms
were treated with 500 nM nicotine for 20 mins up to three times. Between each treatment,
worms were left on nicotine-free plates for 75 mins. Two hours after the third nicotine
treatment, their response to nicotine was then assayed on plates containing 500 nM nicotine.
(C) Behavioral sensitization by repeated intermittent nicotine treatments. If no nicotine was
included during the treatment, no behavioral sensitization was observed. Control represents
data from naive worms in response to a higher concentration of nicotine (5 μM). *p<0.05
(ANOVA with Kruskal-Wallis H-test).
(D) Continuous nicotine treatment fails to induce behavioral sensitization. Worms were
treated with nicotine as in (B), except that the duration of the interval between each
treatment varied as indicated. *p<0.03 (ANOVA with Kruskal-Wallis H-test).
(E) The time course of nicotine sensitization. The protocol was the same as in (B), except
that after the last treatment, worms were incubated on nicotine-free plates for various
lengths of time as indicated. Subsequently, they were analyzed for response to 500 nM
nicotine. *p<0.03 (ANOVA with Kruskal-Wallis H-test). n≥10. Error bars represent SD.
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Figure 3. Nicotine-dependent behavior requires nicotinic receptors
(A) Suppression of behavioral responses to nicotine by DHβE (20 μM). DHβE did not
significantly reduce the basal locomotion rate (Figure S2C). *p<0.005 (Mann-Whitney U-
test).
(B) DHβE induces withdrawal symptoms in nicotine-adapted animals. Nicotine-adapted
animals (16 hrs treatment) were moved to plates containing both DHβE and nicotine.
Control represents data from nicotine-adapted animals assayed on nicotine-containing plates
(no withdrawal treatment). *p<0.03 (ANOVA with Kruskal-Wallis H-test).
(C) Dendrogram of C. elegans nAChRs. Mouse α4, β2 and α7 were included. The nAChR
genes that do not have mutants available are in light gray.
(D) No significant acute response to nicotine is detected in four nAChR mutants. See
experimental procedures for allele names. *p<0.001 (ANOVA with Kruskal-Wallis H-test).
(E) Mouse α4β2 nAChR can restore the acute response to nicotine in acr-16(ok789) mutant
animals. *p<0.02 (ANOVA with Kruskal-Wallis H-test). n≥10. Error bars represent SD.
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Figure 4. Nicotine induces calcium responses in command interneurons that are important for
nicotine-dependent behavior
(A) Neuronal, but not muscular, expression of acr-15 and acr-16 restored the acute response
to nicotine in acr-15(ok1214) and acr-16(ok789) naive animals, respectively. The unc-119
and myo-3 promoter was used to drive expression of acr-15 and acr-16 in neurons and
muscles, respectively. n≥10. Error bars represent SD. *p<0.04 (ANOVA with Kruskal-
Wallis H-test).
(B) Worms lacking the command interneuron AVA do not respond to nicotine incubation.
AVA, AVB, AVD or PVC neurons were ablated by laser microbeam. *p<0.006 (ANOVA
with Kruskal-Wallis H-test).
(C) Nicotine induces robust calcium responses in the command interneuron AVA of live
worms. G-CaMP and DsRed2 was co-expressed as a transgene under the nmr-1 promoter.
AVA was selected for imaging. Nicotine (100 μM) was perfused toward the animal
immobilized on an agarose pad. The percentage change of the ratio of G-CaMP/DsRed2
fluorescence was plotted vs. time. DsRed2 is insensitive to calcium changes (Li et al., 2006).
Shown is a representative trace.
(D) Worms that were behaviorally adapted to nicotine show very little if any response to
nicotine in AVA. Worms that were treated with nicotine overnight as described in Figure 1C
were subjected to imaging for nicotine-induced calcium responses as described in (C).
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(E) Nicotine-induced calcium responses are potentiated in the worms that were behaviorally
sensitized to nicotine. Worms that received three doses of intermittent nicotine treatment as
described in Figure 2 were imaged for nicotine-induced calcium responses as described in
(C).
(F) ACR-15 is critical for nicotine-induced calcium responses. The same G-CaMP transgene
was crossed into the acr-15 mutant background.
(G) Histogram of calcium imaging experiments. The nicotine-induced calcium responses
were greatly reduced in nicotine-adapted wild-type worms and acr-15 naïve worms
(*p<0.001, ANOVA with Dunnett test), but were potentiated in nicotine-sensitized wild-
type worms (*p<0.05, ANOVA with Dunnett test). n≥5. Error bars represent SEM.
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Figure 5. TRPC channels are required for nicotine-dependent behavior
(A) 2-APB blocks wild-type animals’ acute response to nicotine. Naïve wild-type animals
were assayed on nicotine plates with or without (control) 50 μM 2-APB. *p<0.03 (Mann-
Whitney U-test).
(B) Sequence alignment of worm TRP-1 (cTRP-1), worm TRP-2 (cTRP-2), fly TRP (dTRP)
and human TRPC3 (hTRPC3). The ankyrin repeats, coil-coil domain, six putative
transmembrane domains, and TRP domain are indicated by the underlying dashed brackets,
solid brackets, solid lines, and double lines, respectively. (C–D) Gene structure and
mutations of trp-1 (C) and trp-2 (D). The positions of the trans-spliced leader sequence
(SL1), the first Met and the stop codon are indicated. The underlying hollow rectangle
indicates the fragment deleted in the trp-1(sy690) (C) and trp-2(sy691) (D) mutant.
(E) trp-1(sy690) and trp-2(sy691) mutant animals do not respond to acute nicotine treatment.
Ex[Pglr-1::trp-2] and Ex[Pglr-1::trp-1] denotes a transgene expressing TRP-2 and TRP-1
under the glr-1 promoter, respectively. See experimental procedures for allele names.
*p<0.02 (ANOVA with Kruskal-Wallis H-test). n≥10. Error bars represent SD.
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Figure 6. TRP-2 promotes receptor-operated calcium entry in vitro
(A–B) Expression of TRP-2 cDNA in human HEK293T cells promotes receptor-operated
calcium entry. The initial calcium peak represents calcium release from internal calcium
stores. Subsequently, calcium was added to the bath to reveal the activity of receptor-
operated channels. Shown are representative traces of mock-transfected (A, C, E) and
TRP-2-transfected (B, D, F) cells.
(C–D) TRP-2 is permeable to Ba2+.
(E–F) TRP-2 is permeable to Sr2+.
(G) Histogram of TRP-2-dependent activities in HEK293T cells. The percentage ratio
change (Δ340/380 nm) per second during the first 30 seconds, but not the percentage peak
ratio change, was used to quantify receptor-operated channel activity, because Ba2+ and Sr2+
responses did not desensitize.
(H) TRP-2-dependent calcium activity in 293 cells is sensitive to 2-APB and U73122. The
control data (no drug) is a duplicate from (G). 2-APB (100 μM) was applied right before
calcium re-application, while U73122 (10 μM) was added 10 minutes prior to carbachol
perfusion. n≥6. Error bars represent SEM.
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Figure 7. TRPC channels are important for nicotine-induced calcium responses in command
interneurons
(A) Expression of human TRPC3 restores the acute response to nicotine in trp-2(sy691)
mutant animals. hTRPC1, hTRPC3 and hTRPC4 cDNA were expressed as transgenes (i.e.
Ex[Ptrp-2::hTRPC1], Ex[Ptrp-2::hTRPC3] and Ex[Ptrp-2::hTRPC4]) under the trp-2
promoter in trp-2(sy691) mutant animals. n≥10. Error bars represent SD. *p<0.02 (ANOVA
with Kruskal-Wallis H-test).
(B) Nicotine induces robust calcium responses in the command interneuron AVA of live
worms. Nicotine (100 μM) was perfused toward the animal immobilized on an agarose pad.
The percentage change of the ratio of G-CaMP/DsRed2 fluorescence was plotted vs. time.
Shown is a representative trace.
(C–D) Nicotine-induced calcium responses are greatly reduced in trp-2(sy691) (C) and
trp-1(sy690) (D) mutant worms. The same G-CaMP transgene was crossed into the
trp-2(sy691) or trp-1(sy690) mutant background.
(E) Histogram of calcium imaging experiments. The nicotine-induced calcium responses
were greatly reduced in trp-2(sy691) (*p<0.003, ANOVA with Dunnett test) and
trp-1(sy690) mutant worms (*p<0.03, ANOVA with Dunnett test). n≥8. Error bars represent
SEM.
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